| CTRI Number |
CTRI/2024/03/064441 [Registered on: 19/03/2024] Trial Registered Prospectively |
| Last Modified On: |
15/05/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Nutraceutical |
| Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
|
Public Title of Study
|
Effect of high protein supplement on muscle strength, muscle mass and
physical function in elderly population. |
|
Scientific Title of Study
|
A Prospective, Open label, Randomized, Controlled, Three-Arm, Comparative Study to
Determine the Effect of high protein supplement on muscle strength, muscle mass and
physical function in elderly population. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NUN-HFD-007/23 Protocol v3.0 22nd February 2024 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sanjay Mishra |
| Designation |
Prinicipal Investigator |
| Affiliation |
Rumedic Hospital |
| Address |
Rumedic Hospital,
Room No.- 1, Department of general Physician, Rz 52-4/3 Raj Nager Part 1 Street No 9, Old Mehrauli
Rd, near Shiv Saktti Mandir, Palam, New Delhi, 110045
South West DELHI 110045 India |
| Phone |
8527569065 |
| Fax |
|
| Email |
sanmishra75@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Preeti Chhabra |
| Designation |
Co-Investigator |
| Affiliation |
Shri Krishna Super Speciality Institute of Ayurveda |
| Address |
Room N0.-1, Department of Medicine, Shri Krishna Super Speciality Institute of Ayurveda,
48A, Block C4A, Janakpuri, New Delhi, Delhi, 110058
West DELHI 110058 India |
| Phone |
9891008498 |
| Fax |
|
| Email |
drrajchh@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr. Deepti Khanna |
| Designation |
Clinical Research and Claims Capability Leader, HFD |
| Affiliation |
Hindustan Unilever Limited |
| Address |
Hindustan Unilever Limited Nutrition Research and Development Centre Plot Number 67, Sector 32, Gurgaon 122001, Haryana, India
Gurgaon HARYANA 122001 India |
| Phone |
911244097100 |
| Fax |
|
| Email |
deepti.khanna2@unilever.com |
|
|
Source of Monetary or Material Support
|
| Hindustan Unilever Limited Unilever House, B D Sawant Marg Chakala, Andheri East Mumbai
400099, Maharashtra, India |
|
|
Primary Sponsor
|
| Name |
Hindustan Unilever Limited |
| Address |
Hindustan Unilever Limited Nutrition Research and Development Centre Plot
Number 67, Sector 32, Gurgaon 122001, Haryana, India |
| Type of Sponsor |
Pharmaceutical industry-Global |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 3 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Preeti Chhabra |
Skin, Shri Krishna super specialty, Institute of Ayurveda |
48A, Block C4A, Janakpuri, New Delhi, Delhi, 110058 South West DELHI |
8527569065
drrajchh@yahoo.com |
| Dr Sanjay Mishra |
Bensups Hospital |
Street No 75, Dwarka Sector 12, Delhi - 110078 South DELHI |
9891008498
sanmishra75@gmail.com |
| Dr Sanjay Mishra |
Rumedic Hospital |
Rz 52--4/3 Raj Nager Part 1 Street No 9, Old Mehrauli Rd, near Shiv Saktti Mandir, Palam, New Delhi- 110045 South West DELHI |
9891008498
sanmishra75@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 3 |
| Name of Committee |
Approval Status |
| Good Society Ethical Research |
Approved |
| Good Society Ethical Research |
Approved |
| Good Society Ethical Research |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
To Determine the Effect of high protein supplement on muscle strength, muscle mass and physical function in elderly population. |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Horlicks Strength Plus (30 g P-ONS in 150 ml milk) |
30 g P-ONS in 150 ml milk, twice a day (2-3 hours- after breakfast and before dinner) along with lifestyle counselling.
Subject will visit at site on Day 1, Day 28, Day 56 and Day 84. |
| Intervention |
Horlicks Strength Plus (30 g P-ONS in 150 ml water) |
30 g P-ONS in 150 ml water, twice a day (2-3 hours- after breakfast and before dinner) along with lifestyle counselling.
Subject will visit at site on Day 1, Day 28, Day 56 and Day 84. |
| Comparator Agent |
Lifestyle Couselling |
Total duration of the study is 168 days. Subject will visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 and Day 168 |
|
|
Inclusion Criteria
|
| Age From |
60.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1.Physically independent mobile men and post menopausal women above or equal to 60 years of age who are able to rise from a seated position to standing will be considered
2.All participants below the cutoff for 30 second Chair Stand test 30CST will be included in the study 30SCST cutoffs more than 9 for men and more than 8 for women to be considered
3.Participants having normal resting blood pressure or stage I hypertension systolic blood pressure BP greater than or equal to greater than or equal to 130 to 139 mmHg diastolic BP greater than or equal 80 to 89 mmHg will be considered
4.Participants having BMI 20 to 32.5 kg per m2 will be considered
5.Participants or diabetics on stable doses of oral hypoglycemic agents OHA for at least the last 3 months with glycated hemoglobin HbA1C less than or equal to 8 percent will be considered
6.Participants with a normal liver function and or kidney function and CBC or abnormal values which are considered clinically non significant as per investigator
7.The potential participant should not be on any structured resistance or aerobic exercise training program in the previous 6 months
8.Participants should be willing and able to follow the study protocol and protocol related procedures to participate in the study
9.Participants who can understand and provide written informed consent to participate in the study
|
|
| ExclusionCriteria |
| Details |
1. Participants who have had significant weight loss or gain in the past 6 months.
2. Participants having history of having cancer, infectious diseases, unstable cardiac, and/or gastrointestinal disease or poorly controlled diabetes or on insulin injections for diabetes or having alterations of dosages of OHA in the last 3 months.
3. Participants who regularly uses non-steroidal anti-inflammatory drugs or anticoagulants.
4. Participant with any known food allergy (particularly milk) or intolerance to any food or beverages.
5. Any participant who has taken part in a clinical trial in the past 90 days.
6. Participants on an unusual diets or special diet, for whatever reason e.g., keto diet or any other high protein diet, low sodium diet, for two weeks prior to receiving any test product and throughout his/her participation in the study will be excluded.
7. Participants who have had any surgery in the past 6 months will be excluded.
8. Potential participants who are related (e.g., husband and wife or brother and sister) or persons living in the same household (e.g., tenants sharing a household) cannot be
recruited together in this study; one of them will be excluded.
9. The participant is an employee of the Sponsor, or site (CRO) conducting the study. The participant(s) must also not be related to any personnel conducting the study.
10. Participants consuming non-vegetarian foods (more than 2 a week) in their habitual diet. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle strength or physical function on elderly participants after a 12 week period of consumption. |
Subject will visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 and Day 168 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle strength or physical function on elderly participants after a 24 week & period of consumption.
2. To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle mass on elderly participants after 12- & 24-week of consumption.
3. To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on dietary intake of elderly participants after 12- & 24-week of consumption.
|
Subject will visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 & Day 168 |
|
|
Target Sample Size
|
Total Sample Size="120" Sample Size from India="120"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
28/03/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study is a randomized, open label, controlled, parallel, three arm study. One twenty adults men and women aged greater than or equal to 60 years or above with body mass index BMI between 20.0 and 32.5 kg/m2 will be included in the study. Each arm will have 40 participants. The protein supplementation will be given for 24 weeks post randomization. Participants will be divided into 3 equal groups comprising 40 participants each. The 3 groups will be assigned to either of the 3 arms (1, 2, 3) sequenced according to the randomization schedule and subject has to visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 and Day 168 . |